Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation

Completed

Conditions studied: Hematopoietic Stem Cell Transplant

In brief

The purpose of this research study is to perform a serial analysis of immune function using blood cells and sera obtained from patients after vaccination following hematopoietic stem cell transplantation (HSCT). The focus of this study will be to characterize several immune parameters during the clinical course of HSCT and correlate these findings with the effect of vaccination.

Key facts

Study ID

NCT01581164

Run by

University of California, San Francisco

People needed

12

Starts

2011-12-01

Expected to finish

2014-12-01

Last updated by the study team

2015-05-08

Who can join

Age: 5 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have been treated with HSCT.
• Patients must be 5-70 years of age.
• For patients participating in Objective 3: Patients must be immunocompetent (no active GVHD and must be off all immunosuppression)

You may not qualify if…

• Patients who do not wish to participate or unable to provide the necessary blood samples required for the protocol.
• Patients with history of allergic reaction to a vaccination.
• Patient has had Guillain-Barre syndrome.
• Patients who are pregnant or become pregnant.

Where it is running

• University of California, San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.